1. Introduction {#sec1-jcm-07-00487}
===============

Metabolic Syndrome (MetS) contributes to the development of coronary heart disease (CHD) \[[@B1-jcm-07-00487],[@B2-jcm-07-00487],[@B3-jcm-07-00487]\], cardiovascular disease (CVD) \[[@B3-jcm-07-00487]\], and type II diabetes mellitus (T2DM) \[[@B1-jcm-07-00487],[@B2-jcm-07-00487],[@B3-jcm-07-00487]\]. MetS consists of five, interrelated risk factors \[[@B4-jcm-07-00487],[@B5-jcm-07-00487]\]. Individuals presenting three or more of the following risk factors are diagnosed with MetS: Fasting blood glucose (FBG) ≥100 mg/dL, waist circumference (WC) \>102 cm for men and \>88 cm for women, triglycerides (TG) ≥150 mg/dL, high density lipoprotein cholesterol (HDL) \<40 mg/dL for men and \<50 mg/dL for women, and blood pressure (BP) ≥130/85 mmHg \[[@B6-jcm-07-00487]\].

Few studies have investigated the MetS risk of young adults \[[@B1-jcm-07-00487],[@B7-jcm-07-00487]\]. However, CHD is the second leading cause of death in this age group \[[@B1-jcm-07-00487]\], suggesting the need to detect for early warning signs of this disease. Thus, screening for MetS in this population can be beneficial in identifying those at higher risk from CHD development.

The prevalence of obesity has reached epidemic proportions within the Appalachian region \[[@B8-jcm-07-00487],[@B9-jcm-07-00487]\], which extends from Northeastern Mississippi to Southern New York \[[@B10-jcm-07-00487]\], with its epicenter lying entirely within the state of West Virginia (WV) \[[@B11-jcm-07-00487]\]. The Appalachian region is characterized by unhealthy eating behaviors and inactivity, which leads to the increased incidence of chronic disease among this population \[[@B10-jcm-07-00487]\]. Ely et al. recently reported the increased risk of chronic disease, related to excessive weight gain and poor health behaviors, is not realistically perceived by Appalachian residents \[[@B12-jcm-07-00487]\]. Inadequate transportation \[[@B8-jcm-07-00487]\], poverty \[[@B13-jcm-07-00487],[@B14-jcm-07-00487]\], lack of access to medical care \[[@B8-jcm-07-00487],[@B13-jcm-07-00487]\] and lack of insurance are additional factors directly impacting the health disparities of individuals in this region \[[@B13-jcm-07-00487]\]. In 2009, Appalachians were 40% more likely to have diabetes than non-Appalachians \[[@B8-jcm-07-00487]\]. In 2011, the prevalence of diagnosed diabetes was 9.8% within the Appalachian region and 7.8% in the rest of the nation \[[@B15-jcm-07-00487]\].

In Ohio and WV, 25.6% of normal-weight adults display two or more of the following cardio-metabolic abnormalities: High blood pressure, elevated TG, decreased HDL, elevated FBG, and insulin resistance (IR) \[[@B9-jcm-07-00487]\]. An estimated 50% of adults and adolescents residing in WV are obese by Body Mass Index (BMI) classification: Normal weight (18.5--24.9 kg/m^2^), overweight (25.0--29.9 kg/m^2^), and obese (≥30 kg/m^2^) \[[@B8-jcm-07-00487]\]. WV has reported the highest age-adjusted incidence of diabetes as well as the highest diabetes-related deaths in the nation \[[@B8-jcm-07-00487]\].

As many as 30% to 35% of college students are reported to be overweight or obese \[[@B7-jcm-07-00487],[@B16-jcm-07-00487],[@B17-jcm-07-00487]\] and obesity rates have increased most rapidly among individuals 18--29 years old with some college education \[[@B7-jcm-07-00487],[@B16-jcm-07-00487],[@B17-jcm-07-00487],[@B18-jcm-07-00487]\]. First year college students gain weight up to 11 times faster than adults \[[@B1-jcm-07-00487]\]. This increase in weight increases the likelihood of developing MetS risk criteria \[[@B1-jcm-07-00487],[@B7-jcm-07-00487]\]. Increased weight and obesity, particularly abdominal obesity, is directly related to the development of MetS and cardiovascular risk \[[@B5-jcm-07-00487],[@B19-jcm-07-00487]\]. Screening for abnormal lipid values is recommended starting at 20 years old \[[@B1-jcm-07-00487]\]. Therefore, colleges and universities serve as important settings for the surveillance, prevention, and intervention of hyperlipidemia, MetS, and CHD \[[@B20-jcm-07-00487]\]. Targeting young adults that choose to attend post-secondary institutions could aid in the prevention of CVD, CHD, and T2DM since many young people develop a clearer sense of self and establish life-long behavior patterns during college \[[@B21-jcm-07-00487]\].

The few studies of MetS prevalence in college students found that 27% \[[@B17-jcm-07-00487]\], 28% \[[@B1-jcm-07-00487]\], and 30% \[[@B16-jcm-07-00487]\] of students in the Northeast \[[@B1-jcm-07-00487]\] and Midwest \[[@B16-jcm-07-00487],[@B17-jcm-07-00487]\] regions exhibit at least one component of MetS. In the same studies, 5.7% \[[@B16-jcm-07-00487]\], 7.4% \[[@B1-jcm-07-00487]\], and 14.3% \[[@B17-jcm-07-00487]\] of college students had two components of MetS. In the Southern US, 43% of students presented with at least one component of MetS \[[@B7-jcm-07-00487]\]. When the sample was limited to students who were overweight or obese, the rate of at least one component of MetS rose to 82% \[[@B7-jcm-07-00487]\]. Fernandes et al. found that 3.7% of college students presented with three or more MetS risk components \[[@B1-jcm-07-00487]\]. The latest study, conducted by Morrell et al., reported 77.2% of males and 53.8% of females exhibited at least one component of MetS \[[@B22-jcm-07-00487]\]. MetS was present in 9.9% of males and 3.0% females \[[@B22-jcm-07-00487]\]. Not only do overweight \[[@B1-jcm-07-00487],[@B17-jcm-07-00487],[@B22-jcm-07-00487]\] and obese \[[@B1-jcm-07-00487],[@B22-jcm-07-00487]\] students present with MetS \[[@B1-jcm-07-00487]\] and more MetS risk factors \[[@B17-jcm-07-00487],[@B22-jcm-07-00487]\] than normal weight students, but obese students exhibit significantly more MetS criteria than overweight students \[[@B22-jcm-07-00487]\]. Overall, male students were more likely to exhibit MetS risk criteria than female students \[[@B16-jcm-07-00487]\] and the most prevalent MetS risk component was low HDL \[[@B16-jcm-07-00487],[@B17-jcm-07-00487],[@B22-jcm-07-00487]\], then FBG, and TG in decreasing order \[[@B16-jcm-07-00487],[@B17-jcm-07-00487]\].

Due to the overall poorer health and higher risk factors in the Appalachian region discussed previously, young adults in these regions are an important, yet overlooked, demographic to study their MetS risk. This study aims to determine the prevalence of MetS in Appalachian and non-Appalachian students attending West Virginia University.

2. Method {#sec2-jcm-07-00487}
=========

The measures for this cross-sectional study were collected in January and February 2011. Subjects were recruited from West Virginia University. The Institutional Review Board (IRB) at West Virginia University approved the study protocol in advance of commencement.

2.1. Subjects {#sec2dot1-jcm-07-00487}
-------------

Subjects (*n* = 93) were recruited via posted advertisements, in-class announcements, and recruitment E-mails sent by instructors and campus administrators. Students were eligible if they were 18--24 years old; had a BMI \>18.5 kg/m^2^; were a first, second, or third year undergraduate; had regular access to the Internet; were free from life-threatening illnesses or other health conditions; were not pregnant; had no diet- and/or activity-related medical restrictions that prevented accurate physical assessments; they were not currently enrolled in a nutrition course; and they were not majoring in nutrition, exercise science, or health-promotion.

2.2. Measures {#sec2dot2-jcm-07-00487}
-------------

Demographics (e.g., ethnicity), health-related practices (e.g., cigarette and medication use), and Appalachian identity (from self-reported home address) were collected via questionnaire. All clinical, anthropometric, and biochemical measurements were performed by trained staff. Measurements were collected in the fasted state (\>8 h) after participants had changed into light clothing and voided. All female participants were screened for pregnancy.

Systolic and diastolic pressures were measured in triplicate (with 2 min rest intervals) in the left arm midpoint between the shoulder and elbow via an automated cuff (HEM-907XL, Omron; Lake Forest, IL, USA) after subjects were rested in a seated position for five minutes. Height was measured by a wall-mounted, digital stadiometer (Heightronic 235, Quick Medical; Issaquah, WA, USA) with subjects looking straight ahead and maintaining four points of contact (heels, buttocks, shoulder blades, and back of the head) with the wall. Weight was measured by a digital scale (300A, Tanita; Arlington Heights, IL, USA) which also calculated body mass index (BMI) from height input. Waist circumference (WC) was measured in duplicate at the top of the iliac crest to the nearest 0.1 cm using a non-stretchable tape measure with tensometer (Gulick, Creative Health Products; Plymouth, MI, USA). Neck circumference (NC) was measured in duplicate at the point below the larynx to the nearest 0.1 cm with the tape measure used for waist circumference.

Biochemical measures were obtained via finger-stick using a desktop LDX Cholestech Analyzer (LDX, Cholestech; San Diego, CA, USA) following manufacturer's instructions. Analyses for high-density lipoprotein cholesterol (HDL), triglycerides (TG), fasting blood glucose (FBG), C-Reactive Protein (CRP), and low-density lipoprotein cholesterol (LDL) were conducted via direct enzymatic methods by the analyzer. The Cholestech LDX analyzer has been validated for precision and accuracy against traditional laboratory techniques and offers logistical convenience for large-scale health assessments \[[@B23-jcm-07-00487]\]. Hemoglobin A1C (HbA1C) was measured using DCA Vantage. Hemoglobin (Hgb) and hematocrit (Hct) weer measured using HemoPoint A2 (Boerne, TX, USA).

2.3. Statistical Analysis {#sec2dot3-jcm-07-00487}
-------------------------

BMI was categorized as normal weight (18.5--24.9 kg/m^2^), overweight (25.0--29.9 kg/m^2^), and obese (≥30.0 kg/m^2^). MetS and its five individual components were defined by the National Cholesterol Education Program Adult Treatment Panel III: Fasting blood glucose (FBG) ≥100 mg/dL, waist circumference (WC) \>102 cm for men and \>88 cm for women, triglycerides (TG) ≥150 mg/dL, high density lipoprotein cholesterol (HDL) \<40 mg/dL for men and \<50 mg/dL for women, and blood pressure (BP) ≥130/85 mmHg \[[@B6-jcm-07-00487]\]. The presence of ≥3/5 components was categorized as MetS.

Student *t*-tests were performed to identify differences in anthropometric and biochemical measures between males and females and Appalachians and non-Appalachians. Chi-square tests were used to identify associations between prevalence rates of individual components and MetS, and the following subject characteristics: Male, female, Appalachian, and non-Appalachian. The Mantel-Haenszel test was used to assess the ordinal trend between males and females as well as Appalachians and non-Appalachians. Statistical significance was defined as a *p*-value \< 0.05. Statistical analyses were performed using SAS 9.3 statistical software (SAS Institute Inc., Cary, NC, USA).

3. Results {#sec3-jcm-07-00487}
==========

Subjects were 51.6% male and 48.4% female; primarily White (82.8%) followed by Black (10.7%), Latino (3.2%) and Asian (2.2%). Roughly, two thirds of the subjects identified themselves as Appalachian (67.7%) and one third as non-Appalachian (32.3%). The majority (41.9%) of subjects were first year, 30.1% were second year, and 25.8% third year undergraduate students. [Table 1](#jcm-07-00487-t001){ref-type="table"} provides more descriptive characteristics.

[Table 2](#jcm-07-00487-t002){ref-type="table"} shows that average subjects had normal BMIs with no significant differences between male and female) subjects (*p*-value = 0.29). Waist circumference did not differ between male and female subjects (*p*-value = 0.58) ([Table 2](#jcm-07-00487-t002){ref-type="table"}). Males weighed significantly more than females (*p*-value \< 0.01) ([Table 2](#jcm-07-00487-t002){ref-type="table"}). Female students presented with significantly higher HDL levels compared to males (*p* \< 0.01) ([Table 3](#jcm-07-00487-t003){ref-type="table"}). Male students had higher systolic BP (*p*-value \< 0.001), but not diastolic BP than females (*p*-value = 0.60) ([Table 3](#jcm-07-00487-t003){ref-type="table"}). No sex differences were observed for TG and FBG ([Table 3](#jcm-07-00487-t003){ref-type="table"}).

Appalachian and non-Appalachian student comparisons revealed no significant differences in anthropometric measures (height, weight, BMI, and WC) or biochemical measures (HDL, TG and FBG) ([Table 4](#jcm-07-00487-t004){ref-type="table"}). Appalachian students presented with elevated FBG (37.1%), low HDL (35.5%), at-risk WC (21.0%), elevated TG (21.0%), and elevated BP (19.4%). Non-Appalachian students presented with elevated FBG (36.7%) low HDL (36.7%), elevated BP (23.3%), at-risk WC (16.7%) and elevated TG (13.3%) ([Table 5](#jcm-07-00487-t005){ref-type="table"}). The prevalence of individual MetS components was not significantly different between Appalachian and non-Appalachian students.

The most prevalent MetS component in the total sample was elevated FBG (37.6%), followed by low HDL (35.5%), elevated BP (20.4%), at-risk WC (19.4%) and elevated TG (18.3%) ([Table 5](#jcm-07-00487-t005){ref-type="table"}). Male students presented with elevated FBG (47.9%), followed by low HDL (39.6%), elevated BP (31.3%), elevated TG (16.7%), and at-risk WC (8.3%), whereas, female students presented with low HDL (31.1%) and at-risk WC (31.1%), followed by elevated FBG (26.7%), elevated TG (20.0%), and elevated BP (8.9%) ([Table 5](#jcm-07-00487-t005){ref-type="table"}). Overall, significantly more female students exhibited at-risk WC than males (*p* \< 0.01), whereas, significantly more male students displayed elevated BP (*p* \< 0.01) and FBG (*p* \< 0.05) ([Table 5](#jcm-07-00487-t005){ref-type="table"}).

Twenty-eight percent of students presented with zero components of MetS; 33.1% with one component; and 23.7% with two components ([Table 6](#jcm-07-00487-t006){ref-type="table"}). The prevalence of MetS in this population was 15%. Specifically, 10.8% presented with three components, 3.2% with four components, and 1.1% with all five components of MetS ([Table 6](#jcm-07-00487-t006){ref-type="table"}). There was no significant difference between male and female students in MetS prevalence (*p*-value = 0.30) or between Appalachian students and non-Appalachian students (*p*-value = 0.33) ([Table 6](#jcm-07-00487-t006){ref-type="table"}). There were no significant associations between the number of MetS components by sex (*p* = 0.28) or by Appalachian identity (*p* = 0.78) ([Table 6](#jcm-07-00487-t006){ref-type="table"}).

4. Discussion {#sec4-jcm-07-00487}
=============

The prevalence of MetS students at West Virginia University (15.1%) is much higher than what has been reported in previous studies (0.6% to 10%) of MetS prevalence in college students \[[@B1-jcm-07-00487],[@B7-jcm-07-00487],[@B16-jcm-07-00487],[@B17-jcm-07-00487],[@B22-jcm-07-00487]\]. Previous studies have reported the prevalence of MetS in young adults to be 0.6% \[[@B17-jcm-07-00487]\] and 1.3% \[[@B16-jcm-07-00487]\] in the Midwest region, 3.7% \[[@B1-jcm-07-00487]\] in the Northeast region and up to 10% in the Southeast region. Additionally, in the Northeast 7% \[[@B1-jcm-07-00487]\]; and in the Midwest 14% \[[@B17-jcm-07-00487]\] and 6% \[[@B16-jcm-07-00487]\] of students had two MetS risk factors, while 24% had two MetS risk factors in the Appalachian region. Showing that Appalachia has a markedly higher incidence of MetS \[[@B1-jcm-07-00487],[@B7-jcm-07-00487],[@B16-jcm-07-00487],[@B17-jcm-07-00487],[@B22-jcm-07-00487]\] and MetS risk factors \[[@B1-jcm-07-00487],[@B16-jcm-07-00487],[@B17-jcm-07-00487]\] than other regions of the US.

In a direct comparison of West Virginia University students to students from two Northeast universities (NEU1 and NEU2), the prevalence of MetS was significantly greater at WVU than both NEU1 (*p*-value \< 0.05) and NEU2 (*p*-value \< 0.05) \[[@B24-jcm-07-00487]\]. The surprising lack of a significant difference between Appalachian and non-Appalachian student identity and the higher prevalence of MetS in WVU students suggests that an unidentified factor may be mediating the relationship with higher incidence of MetS in this population. One possible factor is BMI. Upon examining correlations between BMI and MetS components significant relationships were found. Specifically, BMI was significantly correlated with students presenting with at-risk WC (*R*^2^ = 0.86, *p* \< 0.05), low HDL (*R*^2^ = −0.43, *p* \< 0.05), elevated BP (*R*^2^ = 0.29, *p* \< 0.05) and increased TG (*R*^2^ = 0.22, *p* \< 0.05). No correlation was found between BMI and impaired FBG measures.

There are several limitations to this study. First, this was a small sample size of students. While this area of study is important, having a larger sample size would have increased the impact of these results. Overall, there was a generally low prevalence of MetS in this sample. Future work would include a larger sample size to have more impactful results.

These data identify the need for university administrators throughout the nation to implement health initiatives to measure BMI and screen for MetS components in students to prevent the development of chronic disease. Data from such screenings for college students will provide researchers, public health officials, and administrators with information to use to design, tailor, and implement effective interventions to prevent chronic disease progression across various university settings.
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jcm-07-00487-t001_Table 1

###### 

Sample descriptive characteristics.

                      Total (*n* = 93)   Percentage (%)
  ------------------- ------------------ ----------------
  Sex                                    
   Female             45                 48.4
   Male               48                 51.6
  Ethnicity                              
   Caucasian          77                 82.8
   African American   10                 10.7
   Hispanic/Latino    3                  3.2
   Asian              2                  2.2
   Not reported       1                  1.1
  Permanent address                      
   Appalachian        63                 67.7
   Non-Appalachian    30                 32.3
  School year                            
   First              39                 41.9
   Second             28                 30.1
   Third              24                 25.8
   Not reported       2                  2.2

jcm-07-00487-t002_Table 2

###### 

Baseline anthropometric measures by sex.

                  All (*n* = 93)   Female (*n* = 45)   Male (*n* = 48)   Sex Differences                    
  --------------- ---------------- ------------------- ----------------- ----------------- -------- ------- -------------
  Height (cm)     171.87           8.94                165.01            5.20              178.30   6.63    \<0.0001 \*
  Weight (kg)     73.04            15.58               68.74             16.53             77.08    13.61   0.0092 \*
  BMI (kg/m^2^)   24.70            4.81                25.25             5.82              24.19    3.61    0.2930
  BF (%)          22.84            10.64               30.22             8.89              15.91    6.79    \<0.0001 \*
  WC (cm)         84.13            15.73               85.07             19.77             83.25    10.80   0.5796
  NC (cm)         35.68            3.70                33.04             3.12              38.17    2.17    \<0.0001 \*

SD: Standard Deviation; BMI: Body Mass Index; BF: Body Fat; WC: Waist Circumference; NC: Neck Circumference; \* indicates significance.

jcm-07-00487-t003_Table 3

###### 

Baseline biochemical measures by sex.

                  All (*n* = 93)   Female (*n* = 45)   Male (*n* = 48)   Sex Differences                    
  --------------- ---------------- ------------------- ----------------- ----------------- -------- ------- -------------
  SBP (mmHg)      117.74           13.23               111.27            9.68              123.80   13.30   \<0.0001 \*
  DBP (mmHg)      69.41            8.97                69.91             9.21              68.94    8.82    0.6038
  LDL-C (mg/dL)   97.73            29.23               100.18            27.00             95.14    31.60   0.4618
  HDL-C (mg/dL)   53.06            18.79               58.84             18.31             47.65    17.76   0.0035 \*
  TC (mg/dL)      165.72           36.54               176.82            38.06             155.30   32.08   0.004 \*
  TG (mg/dL)      99.51            57.69               107.38            61.86             92.13    53.06   0.2043
  FBG (mg/dL)     98.84            13.87               97.38             15.97             100.21   11.57   0.3280
  HBA1c (%)       5.28             0.40                5.31              0.50              5.25     0.29    0.4869

SD: Standard Deviation; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; LDL-C: Low Density Lipoprotein Cholesterol; HDL-C: High Density Lipoprotein Cholesterol; TC: Total Cholesterol; TG: Triglycerides; FBG: Fasting Blood Glucose; HBA1c: Hemoglobin A1C; \* Indicates Significance.

jcm-07-00487-t004_Table 4

###### 

Biochemical and anthropometric measures by region.

                  All (*n* = 93)   Appalachian (*n* = 62)   Non-Appalachian (*n* = 30)   Regional Differences                    
  --------------- ---------------- ------------------------ ---------------------------- ---------------------- -------- ------- ----------
  Height (cm)     171.87           8.94                     170.94                       9.00                   174.22   8.33    0.097
  Weight (kg)     73.04            15.58                    73.19                        16.78                  73.05    13.3    0.968
  BMI (kg/m^2^)   24.70            4.81                     25.04                        5.40                   23.99    3.34    0.332
  BF (%)          22.84            10.64                    23.37                        11.27                  21.45    9.30    0.420
  WC (cm)         84.13            15.37                    83.28                        13.56                  82.67    9.38    0.825
  NC (cm)         35.68            3.70                     35.51                        3.79                   36.12    3.58    0.466
  SBP (mmHg)      117.74           13.23                    117.63                       12.92                  118.07   14.27   0.833
  DBP (mmHg)      69.41            8.97                     70.18                        8.60                   67.93    9.80    0.265
  LDL-C (mg/dL    97.93            29.23                    101.21                       32.39                  87.81    16.50   0.076
  HDL-C (mg/dL)   53.06            18.79                    53.34                        19.55                  52.50    17.75   0.843
  TC (mg/dL)      165.72           36.64                    171.39                       38.58                  152.77   28.43   0.021 \*
  TG (mg/dL)      99.51            57.69                    104.95                       60.17                  87.00    51.64   0.164
  FBG (mg/dL)     98.84            13.87                    99.02                        15.43                  98.30    10.40   0.819
  HBA1c (%)       5.28             0.40                     5.32                         0.44                   5.18     0.29    0.115

SD: Standard Deviation; BMI: Body Mass Index; BF: Body Fat; WC: Waist Circumference; NC: Neck Circumference; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; LDL-C: Low Density Lipoprotein Cholesterol; HDL-C: High Density Lipoprotein Cholesterol; TC: Total Cholesterol; TG: Triglycerides; FBG: Fasting Blood Glucose; HBA1c: Hemoglobin A1C; \* indicates significance.

jcm-07-00487-t005_Table 5

###### 

Rates of individual metabolic syndrome components.

  MetS Component   Number (%) with MetS Component (Total *n*/Percentage %)                                                                   
  ---------------- --------------------------------------------------------- ------------ ------------ ----------- ------------ ------------ --------
  Elevated WC      18 (19.4%)                                                4 (8.3%)     14 (31.1%)   0.0055 \*   13 (21.0%)   5 (16.7%)    0.6259
  Elevated BP      19 (20.4%)                                                15 (31.3%)   4 (8.9%)     0.0075 \*   12 (19.4%)   7 (23.3%)    0.6586
  Elevated TGs     17 (18.3%)                                                8 (16.7%)    9 (20.0%)    0.6777      13 (21.0%)   4 (13.3%)    0.3765
  Elevated FBG     35 (37.6%)                                                23 (47.9%)   12 (26.7%)   0.0345 \*   23 (37.1%)   11 (36.7%)   0.968
  Low HDL-C        33 (35.5%)                                                19 (39.6%)   14 (31.1%)   0.3935      22 (35.5%)   11 (36.7%)   0.9117

App: Appalachian; WC: Waist Circumference; BP: Blood Pressure; TGs: Triglycerides; FBG: Fasting Blood Glucose; HDL-C: High Density Lipoprotein Cholesterol; ^1^ Chi-Square test; \* indicates significance.

jcm-07-00487-t006_Table 6

###### 

Frequency of metabolic syndrome and number of metabolic syndrome components.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Demographic Variable   *n*   Total *n* (%) with MetS   *p*-Value ^1^   Number of MetS Components (Total *n*/Percentage %)   *p*-Value ^2^                                         
  ---------------------- ----- ------------------------- --------------- ---------------------------------------------------- --------------- --------- --------- -------- -------- --------
  Overall                93    14\                       \-              26\                                                  31\             22\       10\       3\       1\       
                               (15.1%)                                   (28.0%)                                              (33.3%)         (23.7%)   (10.8%)   (3.2%)   (1.1%)   

  Sex                                                    0.3033                                                                                                                     0.2770

   Males                 48    9\                        12\             15\                                                  12\             6\        3\        0\                
                               (18.8%)                   (25.0%)         (33.3%)                                              (25.0%)         (12.5%)   (6.3%)    (0.0%)            

   Females               45    5\                        14\             16\                                                  10\             4\        0\        1\                
                               (11.1%)                   (31.1%)         (35.6%)                                              (22.2%)         (8.9%)    (0.0%)    (2.2%)            

  Region                                                 0.3325                                                                                                                     0.7795

   Appalachian           62    11\                       18\             19\                                                  14\             9\        1\        1\                
                               (17.7%)                   (29.0%)         (30.7%)                                              (22.6%)         (14.5%)   (1.6%)    (1.6%)            

   Non-Appalachian       30    3\                        8\              11\                                                  8\              1\        2\        0\                
                               (10.0%)                   (26.7%)         (36.7%)                                              (26.7%)         (3.3%)    (6.7%)    (0.0%)            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MetS: Metabolic Syndrome; ^1^ Chi Square Test; ^2^ Mantel-Haenszel test for trend.
